Filing Details
- Accession Number:
- 0001127602-21-015567
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-05-05 13:00:00
- Reporting Period:
- 2021-05-04
- Accepted Time:
- 2021-05-05 17:02:06
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
882095 | Gilead Sciences Inc | GILD | Biological Products, (No Disgnostic Substances) (2836) | 943047598 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1782135 | Johanna Mercier | Gilead Sciences, Inc. 333 Lakeside Drive Foster City CA 94404 | Chief Commercial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2021-05-04 | 19,496 | $66.09 | 8,068 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- Sale prices reported for the transactions reported here range from $66.08 to $66.115. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.